Large-cap stocks are a staple in every portfolio. They’re well-established, have greater analyst coverage, typically pay dividends, and help shield investors from volatility, undoubtedly significant perks that make them so beloved.
Further, these companies are less likely to face an economic or business circumstance that will cause insolvency.
While many of these stocks no longer enjoy supercharged growth, there are still several currently top-ranked large-caps with impressive growth profiles, including Elevance Health (ELV - Free Report) , Archer Daniels Midland (ADM - Free Report) , and Marathon Petroleum Corp. (MPC - Free Report) .
Below is a chart illustrating the year-to-date performance of all three stocks, with the S&P 500 blended in as a benchmark.
As we can see, on top of impressive growth profiles, all three stocks have witnessed positive momentum in 2022, outperforming the S&P 500 by wide margins.
Let’s take a deeper dive into each one.
Elevance Health
Elevance Health operates as a health benefits company, supporting consumers, families, and communities across the entire care journey to lead healthier lives. The company sports a favorable Zacks Rank #2 (Buy).
The company has found success with its earnings releases as of late, exceeding both top and bottom-line estimates in back-to-back quarters. In its latest print, ELV registered a 6% EPS beat paired with a 1.3% revenue beat.
Further, for those who seek income, ELV’s got that covered; ELV’s annual dividend currently yields 1%, modestly below its Zacks Medical sector average of 1.4%.
While the yield is below its sector average, the company’s 15% five-year annualized dividend growth rate picks up the slack in a big way.
For the cherry on top, Elevance carries an inspiring growth profile, with earnings forecasted to climb 12% in FY22 and a further 12.5% in FY23.
The projected earnings growth comes on top of forecasted Y/Y revenue upticks of 13.7% and 5.3% in FY22 and FY23, respectively.
Archer Daniels Midland
Archer Daniels Midland is a leading producer of food and beverage ingredients and goods made from various agricultural products.
Analysts have upped their earnings outlook across the board over the last several months, helping land the stock into the highly-coveted Zacks Rank #1 (Strong Buy).
Additionally, ADM is a Dividend Aristocrat, showing an exceptional commitment to shareholders through a minimum of 25 consecutive years of increased dividend payouts.
ADM’s annual dividend currently yields 1.7% paired with a payout ratio sitting sustainably at 22% of its earnings. While the yield may be lower than its Zacks sector average, the company’s consistent, reliable, increasing payouts provide a massive boost.
The company carries a strong growth profile for its current fiscal year (FY22), with earnings and revenue forecasted to increase by 42% and 19% Y/Y, respectively.
Still, it’s worth noting that the growth slows down in FY23, with earnings forecasted to decline nearly 15% and revenue indicated to decrease by a marginal 1%.
Marathon Petroleum
Marathon Petroleum Corporation is a leading independent refiner, transporter, and marketer of petrol products with refineries spanning across a vast portion of the United States. MPC sports a Zacks Rank #2 (Buy).
Analysts have substantially upped their earnings outlook across the board over the last several months.
It’s nearly impossible to ignore the company’s growth trajectory; earnings estimates for its current fiscal year suggest an improvement of almost 950% Y/Y. The growth slows down in FY23, with earnings forecasted to take a 34% hit.
The company’s annual dividend currently yields a solid 2.5% paired with a 7% five-year annualized dividend growth rate. Further, MPC pays out 11% of its earnings.
Bottom Line
When thinking of stocks, large-caps are sure to be found in every portfolio. These businesses have proven themselves over time and operate in well-established industries, providing a lower-risk approach.
On top of being shields from volatility, large caps typically have greater analyst coverage and pay consistent dividends.
All three large-cap stocks above – Elevance Health (ELV - Free Report) , Archer Daniels Midland (ADM - Free Report) , and Marathon Petroleum Corp. (MPC - Free Report) – could all be considerations for investors.
All three stocks carry inspiring growth profiles paired with favorable Zacks Ranks, undoubtedly a strong pairing that bodes well for their near-term.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How To Profit From Trillions On Spending For Infrastructure >>
Large-cap stocks are a staple in every portfolio. They’re well-established, have greater analyst coverage, typically pay dividends, and help shield investors from volatility, undoubtedly significant perks that make them so beloved.
Further, these companies are less likely to face an economic or business circumstance that will cause insolvency.
While many of these stocks no longer enjoy supercharged growth, there are still several currently top-ranked large-caps with impressive growth profiles, including Elevance Health (ELV - Free Report) , Archer Daniels Midland (ADM - Free Report) , and Marathon Petroleum Corp. (MPC - Free Report) .
Below is a chart illustrating the year-to-date performance of all three stocks, with the S&P 500 blended in as a benchmark.
As we can see, on top of impressive growth profiles, all three stocks have witnessed positive momentum in 2022, outperforming the S&P 500 by wide margins.
Let’s take a deeper dive into each one.
Elevance Health
Elevance Health operates as a health benefits company, supporting consumers, families, and communities across the entire care journey to lead healthier lives. The company sports a favorable Zacks Rank #2 (Buy).
The company has found success with its earnings releases as of late, exceeding both top and bottom-line estimates in back-to-back quarters. In its latest print, ELV registered a 6% EPS beat paired with a 1.3% revenue beat.
Further, for those who seek income, ELV’s got that covered; ELV’s annual dividend currently yields 1%, modestly below its Zacks Medical sector average of 1.4%.
While the yield is below its sector average, the company’s 15% five-year annualized dividend growth rate picks up the slack in a big way.
For the cherry on top, Elevance carries an inspiring growth profile, with earnings forecasted to climb 12% in FY22 and a further 12.5% in FY23.
The projected earnings growth comes on top of forecasted Y/Y revenue upticks of 13.7% and 5.3% in FY22 and FY23, respectively.
Archer Daniels Midland
Archer Daniels Midland is a leading producer of food and beverage ingredients and goods made from various agricultural products.
Analysts have upped their earnings outlook across the board over the last several months, helping land the stock into the highly-coveted Zacks Rank #1 (Strong Buy).
Additionally, ADM is a Dividend Aristocrat, showing an exceptional commitment to shareholders through a minimum of 25 consecutive years of increased dividend payouts.
ADM’s annual dividend currently yields 1.7% paired with a payout ratio sitting sustainably at 22% of its earnings. While the yield may be lower than its Zacks sector average, the company’s consistent, reliable, increasing payouts provide a massive boost.
The company carries a strong growth profile for its current fiscal year (FY22), with earnings and revenue forecasted to increase by 42% and 19% Y/Y, respectively.
Still, it’s worth noting that the growth slows down in FY23, with earnings forecasted to decline nearly 15% and revenue indicated to decrease by a marginal 1%.
Marathon Petroleum
Marathon Petroleum Corporation is a leading independent refiner, transporter, and marketer of petrol products with refineries spanning across a vast portion of the United States. MPC sports a Zacks Rank #2 (Buy).
Analysts have substantially upped their earnings outlook across the board over the last several months.
It’s nearly impossible to ignore the company’s growth trajectory; earnings estimates for its current fiscal year suggest an improvement of almost 950% Y/Y. The growth slows down in FY23, with earnings forecasted to take a 34% hit.
The company’s annual dividend currently yields a solid 2.5% paired with a 7% five-year annualized dividend growth rate. Further, MPC pays out 11% of its earnings.
Bottom Line
When thinking of stocks, large-caps are sure to be found in every portfolio. These businesses have proven themselves over time and operate in well-established industries, providing a lower-risk approach.
On top of being shields from volatility, large caps typically have greater analyst coverage and pay consistent dividends.
All three large-cap stocks above – Elevance Health (ELV - Free Report) , Archer Daniels Midland (ADM - Free Report) , and Marathon Petroleum Corp. (MPC - Free Report) – could all be considerations for investors.
All three stocks carry inspiring growth profiles paired with favorable Zacks Ranks, undoubtedly a strong pairing that bodes well for their near-term.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How To Profit From Trillions On Spending For Infrastructure >>
Get the latest research report on ADM - FREE
Get the latest research report on MPC - FREE
Get the latest research report on ELV - FREE